Drug Interactions and Side Effects of Morphine and Metoclopramide and Venlafaxine Hcl and Diazepam and Temazepam and Amoxicillin and Dexamethasone and Oramorph Sr and Diclofenac Sodium and Miconazole Nitrate and Lansoprazole and Sutent
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 156075 | May, 16, 2006 | 51 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Morphine | morphine sulfate |
Metoclopramide | metoclopramide hydrochloride |
Venlafaxine Hcl | venlafaxine hydrochloride |
Diazepam | diazepam |
Temazepam | temazepam |
Amoxicillin | amoxicillin |
Dexamethasone | dexamethasone |
Oramorph Sr | morphine sulfate |
Diclofenac Sodium | diclofenac sodium |
Miconazole Nitrate | miconazole nitrate |
Lansoprazole | lansoprazole |
Sutent | sunitinib malate |
| Name |
Aspartate Aminotransferase Decreased |
Blood Albumin Decreased |
Blood Alkaline Phosphatase Increased |
C-reactive Protein Increased |
Chest Pain |
Fibrin D Dimer Increased |
Protein Total Decreased |
Red Blood Cell Count Decreased |
White Blood Cell Count Increased |
Results from eHealthMe : 1028 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Aspartate Aminotransferase Decreased | 2048 (199.22%) |
Blood Albumin Decreased | 2048 (199.22%) |
Blood Alkaline Phosphatase Increased | 2048 (199.22%) |
C-reactive Protein Increased | 2048 (199.22%) |
Chest Pain | 2052 (199.61%) |
Fibrin D Dimer Increased | 2048 (199.22%) |
Protein Total Decreased | 2048 (199.22%) |
Red Blood Cell Count Decreased | 2048 (199.22%) |
White Blood Cell Count Increased | 1024 (99.61%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Chest Pain | 2052 (199.61%) |
Fibrin D Dimer Increased | 2048 (199.22%) |
Red Blood Cell Count Decreased | 2048 (199.22%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: